Annotation Detail for PNPLA4
Basic Information
Top
Pathway ID | Pathway Name |
---|
LIPAS-PWY | triacylglycerol degradation |
Pathway ID | Pathway Name |
---|
hsa00830 | Retinol metabolism |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of PNPLA4 mRNA | decreases expression | 20106945
|
C014794 |
retinol palmitate |
M6PRBP1 protein inhibits the reaction [PNPLA4 protein results in increased hydrolysis of retinol palmitate] | decreases reaction|increases hydrolysis | 16741517
|
C014794 |
retinol palmitate |
PNPLA4 protein results in increased hydrolysis of retinol palmitate | increases hydrolysis | 16741517
|
D014810 |
Vitamin E |
Vitamin E results in decreased expression of PNPLA4 mRNA | decreases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
4.58 | 16050911 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
retinol palmitate |
4.46 | 15984520 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.82 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.24 | 19486331 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
1.93 | 19769572 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
5.57 | 9068938 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.34 | 19224547 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.79 | 12639820 12168785 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.96 | 8708960 |
MESH:D006258 |
Head and Neck Neoplasms |
|
retinol palmitate |
5.54 | 15984520 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
3.18 | 16080930 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
5.16 | 15720958 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.82 | 16490937 16863852 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
4.84 | 14716179 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.23 | 10903974 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
5.08 | 16624496 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.31 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.78 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
6.78 | 12488133 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.12 | 12371664 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
1.91 | 16169303 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.45 | 16863852 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
1.90 | 11062179 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.65 | 16801185 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.31 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.70 | 19348381 18481113 |
MESH:D010033 |
Otitis Media |
|
retinol palmitate |
7.61 | 17303254 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.64 | 12371664 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
3.24 | 15084515 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.34 | 16882103 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.52 | 18709164 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.88 | 16517955 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.85 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.31 | 17120751 |
Pathway ID |
Pathway Name |
---|
KEGG:00830 |
Retinol metabolism |
PharmGKB Accession:PA134910531
Releated disease ID |
Related disease Name |
PA444929 | Mental Retardation |